We are live on ! Find out more
TCB

Thoma Cressey Bravo Portfolio holdings

AUM $59.3M
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
–
Cap. Flow
+$55M
Cap. Flow %
94.13%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$28.1M
2
SEM
Select Medical
SEM
+$26.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
1
Jazz Pharmaceuticals
JAZZ
$15.9B
$31.6M 54.05%
+459,130
New +$28.1M
SEM
2
DELISTED
Select Medical
SEM
$26.8M 45.95%
+6,071,091
New +$26.9M

Similar funds

BCM
BP Capital Management Dallas, Texas $60.1M AUM
CRPX
Charles River Partnership XIII Cambridge, Massachusetts $57.8M AUM
VC
Verizon Communications New York $69.6M AUM
GML
Gems Management Ltd Nassau, Bahamas $70.5M AUM
IIM
InView Investment Management Chicago, Illinois $74.3M AUM
SOM
Stark Offshore Management St. Francis, Wisconsin $38.6M AUM
CFIP
Chicago Fundamental Investment Partners Chicago, Illinois $37.2M AUM
JNI
Joshua Nash II New York $36.8M AUM

Thoma Cressey Bravo's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Thoma Cressey Bravo, which disclosed 2 positions worth $58.4M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Jazz Pharmaceuticals: 459,130 shares worth $31.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Thoma Cressey Bravo's largest Q2 2013 buy was Jazz Pharmaceuticals: 459,130 shares worth $31.6M.
  • Thoma Cressey Bravo's ten largest holdings make up 100% of its $58.4M portfolio in Q2 2013.
  • Thoma Cressey Bravo disclosed 2 positions in Q2 2013, its first 13F filing on record.

Based on Thoma Cressey Bravo's 13F filing for Q2 2013, filed 31 Jul 2013.